[COMPARATIVE STUDY OF THE INCORPORATION OF 32PO4 IN PHOSPHATIDOPEPTIDES AND PHOSPHOPROTEINS OF ISOLATED LIVER CELLS].

M. Ledig,P. Mandel

Biochimica et Biophysica Acta

Abstract:

What problem does this paper attempt to address?

High throughput and rapid isolation of extracellular vesicles and exosomes with purity using size exclusion liquid chromatography

Kshipra S Kapoor,Kristen Harris,Kent A Arian,Lihua Ma,Beatriz Schueng Zancanela,Kaira A Church,Kathleen M McAndrews,Raghu Kalluri

DOI: https://doi.org/10.1016/j.bioactmat.2024.08.002

2024-09-04

Abstract:Extracellular vesicles (EVs) have emerged as potential biomarkers for diagnosing a range of diseases without invasive procedures. Extracellular vesicles also offer advantages compared to synthetic vesicles for delivery of various drugs; however, limitations in segregating EVs from other particles and soluble proteins have led to inconsistent EV retrieval rates with low levels of purity. Here, we report a new high-yield (88.47 %) and rapid (<20 min) EV isolation method termed size exclusion - fast protein liquid chromatography (SE-FPLC). We show SE-FPLC can effectively isolate EVs from multiple sources including EVs derived from human and mouse cells and serum samples. The results indicate that SE-FPLC can successfully remove highly abundant protein contaminants such as albumin and lipoprotein complexes, which can represent a major hurdle in large scale isolation of EVs. The high-yield nature of SE-FPLC allows for easy industrial scaling up of EV production for various clinical utilities. SE-FPLC also enables analysis of small volumes of blood for use in point-of-care diagnostics in the clinic. Collectively, SE-FPLC offers many advantages over current EV isolation methods and offers rapid clinical translation.
Sequencing-Based Protein Analysis of Single Extracellular Vesicles.

Jina Ko,Yongcheng Wang,Kuanwei Sheng,David A. Weitz,Ralph Weissleder

DOI: https://doi.org/10.1021/acsnano.1c00782

IF: 17.1

2021-01-01

ACS Nano

Abstract:Circulating extracellular vesicles (EVs)-biological nanomaterials shed from most mammalian cells-have emerged as promising biomarkers, drug delivery vesicles, and treatment modulators. While different types of vesicles are being explored for these applications, it is becoming clear that human EVs are quite heterogeneous even in homogeneous or monoclonal cell populations. Since it is the surface EV protein composition that will largely dictate their biological behavior, high-throughput single EV profiling methods are needed to better define EV subpopulations. Here, we present an antibody-based immunosequencing method that allows multiplexed measurement of protein molecules from individual nanometer-sized EVs. We use droplet microfluidics to compartmentalize and barcode individual EVs. The barcodes/antibody-DNA are then sequenced to determine protein composition. Using this highly sensitive technology, we detected specific proteins at the single EV level. We expect that this technology can be further adapted for multiplexed protein analysis of any nanoparticle.
Sequential separation and profiling of extracellular vesicles using antibody-aptamer conjugates

Dario Brambilla,Federica Panico,M. Selim Unlu,Marcella Chiari

DOI: https://doi.org/10.26434/chemrxiv-2023-4dbq2

2023-11-29

Abstract:Extracellular vesicles (EVs) are membrane-bound vesicles secreted by cells, exhibiting diverse compositions reflective of their cellular origin. With significant potential as biomarkers for liquid biopsies, EV research has led to various isolation techniques. However, a consensus on the optimal strategy remains elusive. Immunoprecipitation, selectively capturing EVs based on surface markers, is promising but hindered by cost, low yields, and potential damage during release. In this study, we propose an innovative Antibody-Aptamer Conjugate: a three-component separation reagent for the separation of EVs. Combining an EV-specific antibody, a streptavidin-binding aptamer, and a unique barcode DNA sequence, this conjugate serves dual roles, facilitating both EV separation and subsequent multiplexed analysis. We detail the development and validation of the Antibody-Aptamer Conjugate, demonstrating its efficacy in isolating intact EVs from complex samples. The unique barcode DNA sequence enables high-throughput analysis on a DNA microarray chip, addressing limitations of existing methodologies. This approach offers a valid and cost-effective alternative for selective EV isolation and analysis, with implications for diagnostic and therapeutic advancements in liquid biopsy applications.

Chemistry
[The primitive hypoglossal artery. Anatomic and radio-clinical study. Apropos of 2 cases].

G. Arnould,P. Tridon,M. Laxenaire,L. Picard,M. Wéber,G. Gougaud

1968-05-01

Abstract:
Peptide-based capture-and-release purification of extracellular vesicles and statistical algorithm enabled quality assessment

Zachary F. Greenberg,Samantha Ali,Thomas D. Schmittgen,Song Han,Steven J. Hughes,Kiley S. Graim,Mei He

DOI: https://doi.org/10.1101/2024.02.06.578050

2024-02-08

Abstract:Circulating extracellular vesicles (EVs) have gained significant attention for discovering tumor biomarkers. However, isolating EVs with well-defined homogeneous populations from complex biological samples is challenging. Different isolation methods have been found to derive different EV populations carrying different molecular contents, which confounds current investigations and hinders subsequent clinical translation. Therefore, standardizing and building a rigorous assessment of isolated EV quality associated with downstream molecular analysis is essential. To address this need, we introduce a statistical algorithm (ExoQuality Index, EQI) by integrating multiple EV characterizations (size, particle concentration, zeta potential, total protein, and RNA), enabling direct EV quality assessment and comparisons between different isolation methods. We also introduced a novel capture-release isolation approach using a pH-responsive peptide conjugated with NanoPom magnetic beads (ExCy) for simple, fast, and homogeneous EV isolation from various biological fluids. Bioinformatic analysis of next-generation sequencing (NGS) data of EV total RNAs from pancreatic cancer patient plasma samples using our novel EV isolation approach and quality index strategy illuminates how this approach improves the identification of tumor associated molecular markers. Results showed higher human mRNA coverage compared to existing isolation approaches in terms of both pancreatic cancer pathways and EV cellular component pathways using gProfiler pathway analysis. This study provides a valuable resource for researchers, establishing a workflow to prepare and analyze EV samples carefully and contributing to the advancement of reliable and rigorous EV quality assessment and clinical translation.

Bioengineering
Enhanced enrichment of extracellular vesicles for laboratory and clinical research from drop-sized blood samples

Alexa Guerrero-Alba,Sandhya Bansal,Aryan N Sankpal,Geetanjali Mitra,Mohammad Rahman,Ranjithkumar Ravichandran,Christin Poulson,Timothy P Fleming,Michael A Smith,Ross M Bremner,T Mohanakumar,Narendra V Sankpal

DOI: https://doi.org/10.3389/fmolb.2024.1365783

2024-08-15

Abstract:In the realm of biomedical advancement, extracellular vesicles (EVs) are revolutionizing our capacity to diagnose, monitor, and predict disease progression. However, the comprehensive exploration and clinical application of EVs face significant limitations due to the current isolation techniques. The size exclusion chromatography, commercial precipitation reagents, and ultracentrifugation are frequently employed, necessitating skilled operators and entailing challenges related to consistency, reproducibility, quality, and yields. Notably, the formidable challenge of extracellular vesicle isolation persists when dealing with clinical samples of limited availability. This study addresses these challenges by aiming to devise a rapid, user-friendly, and high-recovery EVs isolation technique tailored for blood samples. The NTI-EXO precipitation method demonstrated a 5-fold increase in the recovery of serum EVs compared to current methodologies. Importantly, we illustrate that a mere two drops of blood (∼100 µL) suffice for the recovery of enriched EVs. The integrity and quality of these isolated EVs were rigorously assessed for the size, purity, and contaminants. This method was validated through the successful isolation of EVs from organ transplant recipients to detect disease-specific exosomal markers, including LKB1, SARS-CoV-2 spike protein, and PD-L1. In conclusion, NTI-EXO method can be used for small clinical samples, thereby advancing discoveries in the EV-centric domain and propelling the frontiers of biomedical research and clinical applications.
Rapid and unbiased enrichment of extracellular vesicles via a meticulously engineered peptide

Le Wang,Zhou Gong,Ming Wang,Yi-Zhong Liang,Jing Zhao,Qi Xie,Xiao-Wei Wu,Qin-Ying Li,Cong Zhang,Li-Yun Ma,Si-Yang Zheng,Ming Jiang,Xu Yu,Li Xu

DOI: https://doi.org/10.1016/j.bioactmat.2024.09.023

IF: 18.9

2024-09-27

Bioactive Materials

Abstract:Highlights • We present a novel approach for the unbiased isolation of EVs with high purity. • An artificial insertion peptide was reconfigured and modified to achieve the purpose. • The BAIP system enables unbiased isolation of EVs with ∼80 % recovery in 20 min. • The isolated EVs can be directly utilized for various downstream protein and nucleic acid analyses. • We successfully detected gene mutations in EVs from plasma in clinical samples. Extracellular vesicles (EVs) have garnered significant attention in biomedical applications. However, the rapid, efficient, and unbiased separation of EVs from complex biological fluids remains a challenge due to their heterogeneity and low abundance in biofluids. Herein, we report a novel approach to reconfigure and modify an artificial insertion peptide for the unbiased and rapid isolation of EVs in 20 min with ∼80% recovery in neutral conditions. Moreover, the approach demonstrates exceptional anti-interference capability and achieves a high purity of EVs comparable to standard ultracentrifugation and other methods. Importantly, the isolated EVs could be directly applied for downstream protein and nucleic acid analyses, including proteomics analysis, exome sequencing analysis, as well as the detection of both epidermal growth factor receptor (EGFR) and V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) gene mutation in clinical plasma samples. Our approach offers great possibilities for utilizing EVs in liquid biopsy, as well as in various other biomedical applications. Graphical abstract Download: Download high-res image (513KB) Download: Download full-size image

engineering, biomedical,materials science, biomaterials
Rapid Enrichment and Sensitive Detection of Extracellular Vesicles Through Measuring the Phospholipids and Transmembrane Protein in a Microfluidic Chip.

Yongan Ren,Ke Ge,Danyang Sun,Zichen Hong,Changku Jia,Huan Hu,Fangwei Shao,Bo Yao

DOI: https://doi.org/10.1016/j.bios.2021.113870

IF: 12.545

2021-01-01

Biosensors and Bioelectronics

Abstract:Extracellular vesicles (EVs) have attracted tremendous attention in recent years and quantification of EVs is a key issue in the evaluation of vesicle-based diagnostics and therapeutic development, but it's quite challenging to determine whether higher protein expression signals are due to larger vesicle amount or higher protein content within each vesicle. To solve this problem, herein, we proposed a strategy based on staining phospholipid bilayers of EVs with lipophilic dyes to evaluate their lipid amount, which was subsequently normalized as an internal standard for studying the expression of transmembrane protein (i.e., CD63) on EVs in different samples. In addition, a microfluidic platform based on electrophoresis technology was invented to effectively enrich and detect EVs. Small fluorescent labeling molecules (i.e., uncombined aptamers) were on-chip removed from EVs without pre-separation via ultracentrifugation or ultrafiltration which were indispensable in nanoparticle tracking analysis (NTA) and flow cytometry techniques and the performance of this assay is comparable to NTA. Finally, it was found obvious difference in the expression of CD63 on EVs before and after normalization based on lipid amount in plasma samples. This method is expected to provide more accurate information when comparing the expression levels of EVs biomarkers in different samples.
High-Efficiency Capture and Proteomic Analysis of Plasma-Derived Extracellular Vesicles through Affinity Purification

Gui-Yuan Zhang,Cheng-xiao Ma,Le Ma,Dong Wei,Ya-Nan Wu,Ying Li,Zhe-Hui Xu,Yu-Feng Liu,Yu-Han Cai,Evan Yi-Wen Yu,Ye-Fei Zhu,Hao Zhang

DOI: https://doi.org/10.1101/2024.08.01.605729

2024-08-01

Abstract:Plasma-derived extracellular vesicles (EVs) are promising sources of biomarkers. It is still a challenge to isolate EVs from a small amount of human plasma for downstream proteomic analysis. The separation process is hindered by contamination with high-abundance blood proteins and lipoprotein particles, which adversely impact proteomic analyses. Moreover, although EVs immune-separation via magnetic beads often integrates with flow sorting and western blotting (WB), it lacks compatibility with nanoparticle tracking analysis (NTA) and proteomic analysis. To address these issues, we have developed a functional affinity magnetic bead, EVlent (Extracellular Vesicles isolated Efficiently, Naturally, and Totally), enabling the rapid and efficient separation of EVs from plasma. By optimizing the quantities of magnetic beads and plasma used, we characterized the isolated EVs through WB, NTA, and transmission electron microscopy (TEM), showing a successfully separation of EVs from plasma. Proteomic analysis of these EVs identified over 2,000 proteins and 15,000 peptides from just 100 lower case Greek muL of plasma, and nearly 1,000 proteins from trace samples as small as 5 lower case Greek muL. Additionally, this isolation method significantly reduced contaminants, including plasma proteins and lipoproteins, compared to ultracentrifugation. Finally, we applied this strategy to plasma samples of healthy individuals and those with Parkinson's disease, identifying four potential biomarkers that provide a promising guidance for clinical diagnosis.

Biochemistry
Immobilization coupling with aptamer assisted dual cycle amplification for sensitive sEVs isolation and analysis

Yu He,Ying Ren,Jiawen Tang

DOI: https://doi.org/10.1007/s10529-024-03526-8

2024-09-13

Biotechnology Letters

Abstract:Precise identification of small extracellular vesicles (sEVs) is crucial for improving disease diagnosis and treatments, such as bladder cancer. However, accurate isolation and simultaneously quantification of sEVs remain a huge challenge. We have introduced a new technique that combines immobilization with aptamer-assisted dual cycle amplification to isolate and analyze sEVs with high sensitivity. In this method, the CD9 protein antibody is attached to the plate's surface for the initial identification of sEVs, while an aptamer probe is used to detect the exosomal surface protein CD63. We have created an sEVs-surface method that combines target recognition initiated signal recycling and rolling circle amplification (RCA) for signal amplification. This approach allows for the "AND" logic analysis of dual biomarkers, enabling both sEVs quantification and tracing. The proposed approach has a broad detection range and a low limit of detection. Moreover, the established method showed good stability in detecting sEVs with a low coefficient of variation. Our method can effectively isolate certain sEVs and accurately identify them, making it suitable for many uses in biological science, biomedical engineering, and personalized medicine.

biotechnology & applied microbiology
Rapid isolation of extracellular vesicles from diverse biofluid matrices via capillary-channeled polymer fiber solid-phase extraction micropipette tips

Kaylan K Jackson,Rhonda R Powell,Terri F Bruce,R Kenneth Marcus

DOI: https://doi.org/10.1039/d1an00373a

2021-06-28

Abstract:Extracellular vesicles (EVs) play essential roles in biological systems based on their ability to carry genetic and protein cargos, intercede in cellular communication and serve as vectors in intercellular transport. As such, EVs are species of increasing focus from the points of view of fundamental biochemistry, clinical diagnostics, and therapeutics delivery. Of particular interest are 30-200 nm EVs called exosomes, which have demonstrated high potential for use in diagnostic and targeted delivery applications. The ability to collect exosomes from patient biofluid samples would allow for comprehensive yet remote diagnoses to be performed. While several exosome isolation methods are in common use, they generally produce low recoveries, whose purities are compromised by concomitant inclusion of lipoproteins, host cell proteins, and protein aggregates. Those methods often work on lengthy timescales (multiple hours) and result in very low throughput. In this study, capillary-channeled polymer (C-CP) fiber micropipette tips were employed in a hydrophobic interaction chromatography (HIC) solid-phase extraction (SPE) workflow. Demonstrated is the isolation of exosomes from human urine, saliva, cervical mucus, serum, and goat milk matrices. This method allows for quick (<15 min) and low-cost (<$1 per tip) isolations at sample volume and time scales relevant for clinical applications. The tip isolation was evaluated using absorbance (scattering) detection, nanoparticle tracking analysis (NTA), and transmission electron microscopy (TEM). Exosome purity was assessed by Bradford assay, based on the removal of free proteins. An enzyme-linked immunosorbent assay (ELISA) to the CD81 tetraspanin protein was used to confirm the presence of the known exosomal-biomarker on the vesicles.
Development of complementary analytical methods to characterize extracellular vesicles

Cindy Nix,Sanije Sulejman,Marianne Fillet

DOI: https://doi.org/10.1016/j.aca.2024.343171

2024-11-15

Abstract:Background: Extracellular vesicles (EVs) are involved in intercellular communication and various biological processes. They hold clinical promise for the diagnosis and management of a wide range of pathologies, including cancer, cardiovascular diseases and degenerative diseases, and are of interest as regenerative therapies. Understanding the complex structure of these EVs is essential to perceive the current challenges associated with their analysis and characterization. Today, challenges remain in terms of access to high-yield, high-purity isolation methods, as well as analytical methods for characterizing and controlling the quality of these products for clinical use. Results: We isolated EVs from the same immortalized human cell culture supernatant using two commonly used approaches, namely differential ultracentrifugation and membrane affinity. Then we evaluated EV morphology, size, zeta potential, particle and protein content, as well as protein identity using cryogenic electron microscopy, nanoparticle tracking analysis, asymmetric field flow fractionation (AF4) and size exclusion chromatography (SEC) coupled to multi angle light scattering, bicinchoninic acid assay, electrophoretic light scattering, western blotting and high-resolution mass spectrometry. Compared to membrane affinity isolation, dUC is a more efficient isolation process for obtaining particles with the characteristics expected for EVs and more specifically for exosomes. To validate an isolation process, cryogenic electron microscopy is essential to confirm vesicles with membranes. High resolution mass spectrometry is powerful for understanding the mechanism of action of vesicles. Separative methods, such as AF4 and SEC, are interesting for separating vesicle subpopulations and contaminants. Significance: This study provides a critical assessment of eight different techniques for analyzing EVs, some of which are mandatory for in-depth characterization and deciphering, while others are more appropriate for routine analysis, once the production and isolation process has been validated. The strengths and limitations of the different approaches used are highlighted.
High-throughput, multiplexed quantification, and sorting of single EVs at single-molecule level

Juhwan Park,Michelle Feng,Jingbo Yang,Hanfei Shen,Zhiyuan Qin,Wei Guo,David Issadore

DOI: https://doi.org/10.1101/2024.10.31.621423

2024-11-02

Abstract:We have developed a platform for the high-throughput, multiplexed, and ultra-sensitive profiling of individual extracellular vesicles (EVs) directly in plasma, which we call BDEVS - Agarose Bead-based Digital Single Molecule-Single EV Sorting. Unlike conventional approaches, BDEVS achieves single molecule sensitivity and moderate multiplexing (demonstrated 3-plex) without sacrificing the throughput (processing ten thousand of EVs per minute) necessary to resolve EVs directly in human plasma. Our platform integrates rolling circle amplification (RCA) of EV surface proteins, which are cleaved from single EVs, and amplified within agarose droplets, followed by flow cytometry-based readout and sorting, overcoming steric hindrance, non-specific binding, and the lack of quantitation of multiple proteins on EVs that have plagued earlier approaches. We evaluated the analytical capabilities of BDEVS through head-to-head comparison with gold-standard technologies, and demonstrated a ~100x improvement in the limit of detection of EV subpopulations. We demonstrate the high throughput (~100k beads / minute) profiling of individual EVs for key immune markers PD-L1, CD155, and the melanoma tumor marker TYRP-1, and showed that BDEVS can precisely quantify and sort EVs, offering unprecedented resolution for analyzing tumor-immune interactions and detecting rare EV subpopulations in complex clinical specimens. We demonstrate BDEVS's potential as a transformative tool for EV-based diagnostics and therapeutic monitoring in the context of cancer immunology by analyzing plasma samples from patients with melanoma, where EV heterogeneity plays a critical role in disease progression and response to therapy.

Bioengineering
An Isolation System to Collect High Quality and Purity Extracellular Vesicles from Serum

Jian Yang,Xin Gao,Xiaotao Xing,Haisen Huang,Qi Tang,Shixing Ma,Xun Xu,Cheng Liang,Maojiao Li,Li Liao,Weidong Tian

DOI: https://doi.org/10.2147/ijn.s328325

IF: 7.033

2021-09-01

International Journal of Nanomedicine

Abstract:PURPOSE: Extracellular vesicles (EVs) are membrane-encapsulated nanoparticles that function as carriers and play a role in intercellular communication. There are a large number of EVs in the blood and serve as an indicator of pathophysiological conditions. Studies on the basics and application of EVs are hampered by the limitations of current protocols to isolate EVs from blood. However, current isolation methods are difficult to achieve a balance between yield and purity.METHODS: Firstly, we use Sepharose-4B to build a self-made size exclusion chromatography (SEC) column and perform separation and characteristics. Then, we use the SEC column to systematically compare the efficiency with the most common EV isolation methods: Ultracentrifugation (UC) and total exosomes isolation commercial kit (TEI). The EVs isolated through different methods were characterized the yield and size of EVs, analyzed their protein profiles, the morphology and purity were observed under the transmission electron microscope. To further improve the quality and purity, we combined SEC and UC methods and established a two-steps method to isolated EVs from serum.RESULTS: Self-made SEC column can well separate EVs from complex serum protein, and EVs enriched in the 8-13 fractions with good morphology and yield. By systematically compare SEC with the commonly used UC and TEI kit, SEC is outstanding in all aspects and balances both isolation purity and yield. However, using the SEC method alone still has certain limitations and residual impurities. The SEC+UC combined method can cleverly solve the shortcomings of SEC and optimize the quality and purity of EVs from serum, which is much better than using one method alone.CONCLUSION: Our study presents the combination of size-exclusion chromatography and ultracentrifugation as a feasible and time-saving method to isolate high-quality and purity extracellular vesicles from serum.

pharmacology & pharmacy,nanoscience & nanotechnology
Comparison of extracellular vesicle isolation processes for therapeutic applications

Soraya Williams,Maria Fernandez-Rhodes,Alice Law,Ben Peacock,Mark P Lewis,Owen G Davies

DOI: https://doi.org/10.1177/20417314231174609

2023-05-23

Abstract:While extracellular vesicles (EVs) continue to gain interest for therapeutic applications, their clinical translation is limited by a lack of optimal isolation methods. We sought to determine how universally applied isolation methods impact EV purity and yield. EVs were isolated by ultracentrifugation (UC), polyethylene glycol precipitation, Total Exosome Isolation Reagent, an aqueous two-phase system with and without repeat washes or size exclusion chromatography (SEC). EV-like particles could be detected for all isolation methods but varied in their purity and relative expression of surface markers (Alix, Annexin A2, CD9, CD63 and CD81). Assessments of sample purity were dependent on the specificity of characterisation method applied, with total particle counts and particle to protein (PtP) ratios often not aligning with quantitative measures of tetraspanin surface markers obtained using high-resolution nano-flow cytometry. While SEC resulted in the isolation of fewer particles with a relatively low PtP ratio (1.12 × 107 ± 1.43 × 106 vs highest recorded; ATPS/R 2.01 × 108 ± 1.15 × 109, p ⩽ 0.05), EVs isolated using this method displayed a comparatively high level of tetraspanin positivity (e.g. ExoELISA CD63⁺ particles; 1.36 × 1011 ± 1.18 × 1010 vs ATPS/R 2.58 × 1010 ± 1.92 × 109, p ⩽ 0.001). Results originating from an accompanying survey designed to evaluate pragmatic considerations surrounding method implementation (e.g. scalability and cost) identified that SEC and UC were favoured for overall efficiency. However, reservations were highlighted in the scalability of these methods, which could potentially hinder downstream therapeutic applications. In conclusion, variations in sample purity and yield were evident between isolation methods, while standard non-specific assessments of sample purity did not align with advanced quantitative high-resolution analysis of EV surface markers. Reproducible and specific assessments of EV purity will be critical for informing therapeutic studies.
Isolation and enrichment of extracellular vesicles with double‐positive membrane protein for subsequent biological studies

Chunchen Liu,Huixian Lin,Haiyang Yu,Xueying Mai,Weilun Pan,Jingyun Guo,Tong Liao,Junjie Feng,Ye Zhang,Bo Situ,Lei Zheng,Bo Li

DOI: https://doi.org/10.1002/adhm.202303430

IF: 10

2023-11-09

Advanced Healthcare Materials

Abstract:Abstract The isolation and enrichment of specific extracellular vesicle (EV) subpopulations are essential in the context of precision medicine. However, the current methods predominantly rely on a single‐positive marker and are susceptible to interference from soluble proteins or impurities. This limitation represents a significant obstacle to the widespread application of EVs in biological research. Herein, we propose a novel approach that utilizes proximity ligation assay (PLA) and DNA‐RNA hybridization to facilitate the binding of two proteins on the EV membrane in advance enabling the isolation and enrichment of intact EVs with double‐positive membrane proteins followed by using functionalized magnetic beads for capture and enzymatic cleavage for isolated EVs release. The isolated subpopulations of EVs can be further utilized for cellular uptake studies, high‐throughput small RNA sequencing, and breast cancer diagnosis. Hence, developing and implementing a specialized system for isolating and enriching a specific subpopulation of extracellular vesicles can enhance basic and clinical research in this field. This article is protected by copyright. All rights reserved

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy

Karina P. De Sousa,Izadora Rossi,Mahamed Abdullahi,Marcel Ivan Ramirez,Dan Stratton,Jameel Malhador Inal

DOI: https://doi.org/10.1002/wnan.1835

2022-08-05

Abstract:Fundamental research on EV isolation, standardization and characterisation will bring about translational medical diagnostics and therapy. Extracellular vesicles (EVs) are a unique and heterogeneous class of lipid bilayer nanoparticles secreted by most cells. EVs are regarded as important mediators of intercellular communication in both prokaryotic and eukaryotic cells due to their ability to transfer proteins, lipids and nucleic acids to recipient cells. In addition to their physiological role, EVs are recognized as modulators in pathological processes such as cancer, infectious diseases, and neurodegenerative disorders, providing new potential targets for diagnosis and therapeutic intervention. For a complete understanding of EVs as a universal cellular biological system and its translational applications, optimal techniques for their isolation and characterization are required. Here, we review recent progress in those techniques, from isolation methods to characterization techniques. With interest in therapeutic applications of EVs growing, we address fundamental points of EV‐related cell biology, such as cellular uptake mechanisms and their biodistribution in tissues as well as challenges to their application as drug carriers or biomarkers for less invasive diagnosis or as immunogens. This article is categorized under: Diagnostic Tools > Biosensing Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease
Droplet microfluidic platform for extracellular vesicle isolation based on magnetic bead handling

Alessio Meggiolaro,Valentina Moccia,Alessandro Sammarco,Paola Brun,Carlotta Caterina Damanti,Beatrice Crestani,Lara Mussolin,Matteo Pierno,Giampaolo Mistura,Valentina Zappulli,Davide Ferraro

DOI: https://doi.org/10.1016/j.snb.2024.135583

IF: 9.221

2024-03-08

Sensors and Actuators B Chemical

Abstract:Extracellular vesicles (EVs) are rapidly gaining in popularity as biomarkers of various diseases, acting as cargoes of valuable information from the cell of origin. Despite their important value, their current use in clinical practice is still limited. Among the limiting factors, one of the most critical are the challenges regarding their isolation. In fact, conventional approaches are characterized by low purity and throughput, or poor reproducibility. Here, we present a droplet microfluidic platform specifically developed for EV isolation by affinity capture with magnetic beads. This platform is capable of processing large sample volumes (2 mL) in a relatively short time (4.5 hours), with considerable automation. In detail, EVs and magnetic beads are co-encapsulated within the same droplet, which acts promoting their mixing due to the spontaneous recirculation; this continuous agitation prevents any loss usually caused by bead sedimentation and promotes the EV capturing. Our droplet microfluidic protocol is compared to a commercially available method, showing a shorter required incubation time (about 2.5 times) and a higher capture efficiency (2.5-folds). The microfluidic approach is therefore positively evaluated in terms of protein content, EV quantification and microRNA cargo analysis.

chemistry, analytical,electrochemistry,instruments & instrumentation
High-throughput capture and in situ protein analysis of extracellular vesicles by chemical probe-based array

Xin Feng,Ao Shen,Wei Zhang,Shengnan Jia,Anton Iliuk,Yuling Wang,Wenke Zhang,Ying Zhang,W Andy Tao,Lianghai Hu

DOI: https://doi.org/10.1038/s41596-024-01082-z

2024-10-22

Abstract:Extracellular vesicles (EVs) are small particles with phospholipid bilayers that carry a diverse range of cargoes including nucleic acids, proteins and metabolites. EVs have important roles in various cellular processes and are increasingly recognized for their ubiquitous role in cell-cell communications and potential applications in therapeutics and diagnostics. Although many methods have been developed for the characterization and measurement of EVs, analyzing them from biofluids remains a challenge with regard to throughput and sensitivity. Recently, we introduced an approach to facilitate high-throughput analysis of EVs from trace amounts of sample. In this method, an amphiphile-dendrimer supramolecular probe (ADSP) is coated onto a nitrocellulose membrane for array-based capture and to enable an in situ immunoblotting assay. Here, we describe the protocol for our array-based method of EV profiling. We describe an enhanced version of the method that incorporates an automated printing workstation, ensuring high throughput and reproducibility. We further demonstrate the use of our array to profile specific glycosylations on the EV surface using click chemistry of an azide group introduced by metabolic labeling. In this protocol, the synthesis of ADSP and the fabrication of ADSP nitrocellulose membrane array can be completed on the same day. EVs are efficiently captured from biological or clinical samples through a 30-min incubation, followed by an immunoblotting assay within a 3-h window, thus providing a high-throughput platform for EV isolation and in situ targeted analysis of EV proteins and their modifications.
Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium

Liang Dong,Richard C. Zieren,Kengo Horie,Chi‐Ju Kim,Emily Mallick,Yuezhou Jing,Mingxiao Feng,Morgan D. Kuczler,Jordan Green,Sarah R. Amend,Kenneth W. Witwer,Theo M. de Reijke,Yoon‐Kyoung Cho,Kenneth J. Pienta,Wei Xue

DOI: https://doi.org/10.1002/jev2.12044

2020-12-01

Journal of Extracellular Vesicles

Abstract:One of the challenges that restricts the evolving extracellular vesicle (EV) research field is the lack of a consensus method for EV separation. This may also explain the diversity of the experimental results, as co-separated soluble proteins and lipoproteins may impede the interpretation of experimental findings. In this study, we comprehensively evaluated the EV yields and sample purities of three most popular EV separation methods, ultracentrifugation, precipitation and size exclusion chromatography combined with ultrafiltration, along with a microfluidic tangential flow filtration device, Exodisc, in three commonly used biological samples, cell culture medium, human urine and plasma. Single EV phenotyping and density-gradient ultracentrifugation were used to understand the proportion of true EVs in particle separations. Our findings suggest Exodisc has the best EV yield though it may co-separate contaminants when the non-EV particle levels are high in input materials. We found no 100% pure EV preparations due to the overlap of their size and density with many non-EV particles in biofluids. Precipitation has the lowest sample purity, regardless of sample type. The purities of the other techniques may vary in different sample types and are largely dependent on their working principles and the intrinsic composition of the input sample. Researchers should choose the proper separation method according to the sample type, downstream analysis and their working scenarios.

cell biology

[COMPARATIVE STUDY OF THE INCORPORATION OF 32PO4 IN PHOSPHATIDOPEPTIDES AND PHOSPHOPROTEINS OF ISOLATED LIVER CELLS].

High throughput and rapid isolation of extracellular vesicles and exosomes with purity using size exclusion liquid chromatography

Sequencing-Based Protein Analysis of Single Extracellular Vesicles.

Sequential separation and profiling of extracellular vesicles using antibody-aptamer conjugates

[The primitive hypoglossal artery. Anatomic and radio-clinical study. Apropos of 2 cases].

Peptide-based capture-and-release purification of extracellular vesicles and statistical algorithm enabled quality assessment

Enhanced enrichment of extracellular vesicles for laboratory and clinical research from drop-sized blood samples

Rapid and unbiased enrichment of extracellular vesicles via a meticulously engineered peptide

Rapid Enrichment and Sensitive Detection of Extracellular Vesicles Through Measuring the Phospholipids and Transmembrane Protein in a Microfluidic Chip.

High-Efficiency Capture and Proteomic Analysis of Plasma-Derived Extracellular Vesicles through Affinity Purification

Immobilization coupling with aptamer assisted dual cycle amplification for sensitive sEVs isolation and analysis

Rapid isolation of extracellular vesicles from diverse biofluid matrices via capillary-channeled polymer fiber solid-phase extraction micropipette tips

Development of complementary analytical methods to characterize extracellular vesicles

High-throughput, multiplexed quantification, and sorting of single EVs at single-molecule level

An Isolation System to Collect High Quality and Purity Extracellular Vesicles from Serum

Comparison of extracellular vesicle isolation processes for therapeutic applications

Isolation and enrichment of extracellular vesicles with double‐positive membrane protein for subsequent biological studies

Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy

Droplet microfluidic platform for extracellular vesicle isolation based on magnetic bead handling

High-throughput capture and in situ protein analysis of extracellular vesicles by chemical probe-based array

Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium